Stocks and Investing Stocks and Investing
Mon, July 1, 2024

Matthew O"Brien Downgraded (ZBH) to Hold and Decreased Target to $115 on, Jul 1st, 2024


Published on 2024-10-28 12:11:40 - WOPRAI, Matthew O'Brien
  Print publication without navigation


Matthew O"Brien of Piper Sandler, Downgraded "Zimmer Biomet Holdings, Inc." (ZBH) to Hold and Decreased Target from $140 to $115 on, Jul 1st, 2024.

Matthew has made no other calls on ZBH in the last 4 months.

There are 8 other peers that have a rating on ZBH. Out of the 8 peers that are also analyzing ZBH, 5 agree with Matthew"s Rating of Hold. Following are those relevant analyst calls for the last 4 months;

Mike Matson of "Needham" Reiterated at Hold on, Thursday, May 30th, 2024
David Roman of "Goldman Sachs" Initiated at Hold and Held Target at $129 on, Thursday, May 30th, 2024
Richard Newitter of "Truist Securities" Maintained at Hold with Decreased Target to $130 on, Friday, May 3rd, 2024
Vijay Kumar of "Evercore ISI Group" Maintained at Hold with Increased Target to $130 on, Thursday, April 4th, 2024
Joanne Wuensch of "Citigroup" Maintained at Hold with Increased Target to $140 on, Wednesday, April 3rd, 2024

These are the ratings of the 3 analyists that currently disagree with Matthew;

Matt Miksic of "Barclays" Maintained at Sell with Decreased Target to $125 on, Friday, May 31st, 2024
David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $150 on, Tuesday, May 21st, 2024
Steven Lichtman of "Oppenheimer" Maintained at Buy with Increased Target to $155 on, Friday, May 3rd, 2024

Contributing Sources